Enock Kagimu

Kampala, C, Uganda

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Central Nervous System Toxoplasmosis is an Under-Recognized Opportunistic infection in Uganda.

Central Nervous System Toxoplasmosis is an Under-Recognized Opportunistic infection in Uganda.

Journal: Journal of tropical medicine
Published: January 30, 2026

Pulmonary Aspergillosis Treated With Oral Amphotericin B (MAT2203) in a Patient With HIV-Related Cryptococcal Meningitis.

Pulmonary Aspergillosis Treated With Oral Amphotericin B (MAT2203) in a Patient With HIV-Related Cryptococcal Meningitis.

Journal: Clinical case reports
Published: January 10, 2026

Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis.

Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis.

Journal: The Journal of infectious diseases
Published: December 22, 2025

Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis.

Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis.

Journal: The New England journal of medicine
Published: December 17, 2025

CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.

CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.

Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025

Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.

Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.

Journal: The Journal of infectious diseases
Published: September 30, 2025

Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.

Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 15, 2025

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.

Journal: The lancet. HIV
Published: May 09, 2025

Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease.

Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease.

Journal: AIDS (London, England)
Published: February 12, 2025

Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.

Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 19, 2025

The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022.

The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022.

Journal: Medical mycology
Published: September 09, 2024

Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial.

Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial.

Journal: Wellcome open research
Published: June 03, 2024
Showing 1-12 of 40

Last Updated: 09/26/2026